SOLIGENIX, INC. Accounts and Other Receivables, Net, Current
SOLIGENIX, INC. (SNGX) had Accounts and Other Receivables, Net, Current of $0 as of 2011-09-30, per its 10-Q filed 2011-11-14.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AccountsAndOtherReceivablesNetCurrent · last filed 2011-11-14
- 2011-09-30: Accounts and Other Receivables, Net, Current $0.00.
- 2011-06-30: Accounts and Other Receivables, Net, Current $4.32K.
- 2010-12-31: Accounts and Other Receivables, Net, Current $251.86K.
| Period end | Accounts and Other Receivables, Net, Current |
|---|---|
| 2011-09-30 | $0.00 10-Q · filed 2011-11-14 |
| 2011-06-30 | $4.32K 10-Q · filed 2011-08-12 |
| 2010-12-31 | $251.86K 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |